Ohio Governor Mike DeWine signed Executive Order 2022-17-D on Thursday, to suspend the normal rule making process to allow the State of Ohio Board of Pharmacy to classify all products containing tianeptine, as a Schedule I controlled substance.
According to the Federal Drug Administration (FDA) tianeptine is an antidepressant drug that is not approved by the United States for medical use. The FDA has warned that many companies are illegally marketing and selling products containing tianeptine to the public with unproven beneficial claims (i.e., dietary supplement, treatment for anxiety, depression, or opioid disorder). Effective December 22, 2022, no one may sell or pocess any product containing tianeptine in the state of Ohio.
Read More